Because of the heterogeneous nature of intra-tumor development, it was necessary to developed highly selective and sensitive methods to detect the low-abundance EGFR mutations present in various clinically available samples, such as FFPE tissue sections. This evidence concerns the gene EGFR and neoplasm.